| Q36102621 | A new self: MHC-class-I-independent natural-killer-cell self-tolerance |
| Q27348758 | A novel system of polymorphic and diverse NK cell receptors in primates |
| Q36371883 | A signal peptide derived from hsp60 binds HLA-E and interferes with CD94/NKG2A recognition |
| Q44406144 | A single major chromosomal region controls natural killer cell-like activity in rainbow trout |
| Q28610391 | A structural perspective on MHC class I recognition by killer cell immunoglobulin-like receptors |
| Q35847508 | A subset of natural killer cells achieves self-tolerance without expressing inhibitory receptors specific for self-MHC molecules |
| Q37766751 | Activating and inhibitory receptors of natural killer cells |
| Q36652183 | Activation and self-tolerance of natural killer cells |
| Q37346066 | Activation of natural killer cells inhibits liver fibrosis: a novel strategy to treat liver fibrosis |
| Q35828150 | Activation of natural killer cells: underlying molecular mechanisms revealed |
| Q38095771 | Adaptive reconfiguration of the human NK‐cell compartment in response to cytomegalovirus: A different perspective of the host‐pathogen interaction |
| Q60212988 | Amelioration of acute graft-versus-host disease by NKG2A engagement on donor T cells |
| Q33702486 | An MHC class Ib-restricted CD8+ T cell response to lymphocytic choriomeningitis virus |
| Q33731831 | An affinity/avidity model of peripheral T cell regulation |
| Q36367869 | An invariant T cell receptor alpha chain defines a novel TAP-independent major histocompatibility complex class Ib-restricted alpha/beta T cell subpopulation in mammals |
| Q30918649 | Analysis of Qa-1(b) peptide binding specificity and the capacity of CD94/NKG2A to discriminate between Qa-1-peptide complexes |
| Q44903222 | Analysis of regulatory CD8 T cells in Qa-1-deficient mice |
| Q33664396 | Analysis of the cellular mechanism underlying inhibition of EAE after treatment with anti-NKG2A F(ab')2 |
| Q47934441 | Assessment of Cmv1 candidates by genetic mapping and in vivo antibody depletion of NK cell subsets |
| Q34465877 | Balancing natural killer cell activation through paired receptors |
| Q28509994 | Bone marrow allograft rejection mediated by a novel murine NK receptor, NKG2I |
| Q42944243 | CD1d-glycolipid tetramers: A new tool to monitor natural killer T cells in health and disease |
| Q39172071 | CD4 CTL, a Cytotoxic Subset of CD4+ T Cells, Their Differentiation and Function. |
| Q34046167 | CD4 T-cell help programs a change in CD8 T-cell function enabling effective long-term control of murine gammaherpesvirus 68: role of PD-1-PD-L1 interactions. |
| Q39570193 | CD94 is essential for NK cell-mediated resistance to a lethal viral disease |
| Q52014778 | CD94-NKG2A receptors regulate antiviral CD8(+) T cell responses |
| Q34987153 | Chronic alcohol consumption enhances iNKT cell maturation and activation |
| Q36800512 | Cis interactions of immunoreceptors with MHC and non-MHC ligands |
| Q41993469 | Comparative analysis of NK-cell receptor expression and function across primate species: Perspective on antiviral defenses |
| Q24816578 | Comparative genomics of natural killer cell receptor gene clusters. |
| Q27637067 | Conformational plasticity revealed by the cocrystal structure of NKG2D and its class I MHC-like ligand ULBP3 |
| Q28212878 | Conservation and Variation in Human and Common Chimpanzee CD94 and NKG2 Genes |
| Q60146888 | Conserved lipid and peptide presentation functions of nonclassical class I molecules |
| Q52568328 | Coreceptors and Their Ligands in Epithelial γδ T Cell Biology |
| Q40653237 | Correction of Defects Responsible for Impaired Qa-2 Class Ib MHC Expression on Melanoma Cells Protects Mice from Tumor Growth |
| Q40047518 | Critical role of Qa1b in the protection of mature dendritic cells from NK cell-mediated killing |
| Q41216588 | Crystal structure of Qa-1a with bound Qa-1 determinant modifier peptide |
| Q37785488 | Current perspectives of natural killer cell education by MHC class I molecules |
| Q27009135 | Current perspectives on natural killer cell education and tolerance: emerging roles for inhibitory receptors |
| Q33949213 | Cytomegalovirus MHC class I homologues and natural killer cells: an overview |
| Q46091534 | DAP12-deficient mice fail to develop autoimmunity due to impaired antigen priming |
| Q36369610 | Dendritic cell maturation overrules H-2D-mediated natural killer T (NKT) cell inhibition: critical role for B7 in CD1d-dependent NKT cell interferon gamma production |
| Q36557562 | Detecting the unusual: natural killer cells |
| Q33769518 | Development and function of CD94-deficient natural killer cells |
| Q33632405 | Development and tolerance of natural killer cells. |
| Q35606439 | Development of Murine Hepatic NK Cells during Ontogeny: Comparison with Spleen NK Cells |
| Q45404645 | Differential induction of CD94 and NKG2 in CD4 helper T cells. A consequence of influenza virus infection and interferon-gamma? |
| Q41683616 | Direct assessment of MHC class I binding by seven Ly49 inhibitory NK cell receptors. |
| Q34207553 | Divergent and convergent evolution of NK-cell receptors |
| Q34626935 | Diverse roles of non-diverse molecules: MHC class Ib molecules in host defense and control of autoimmunity |
| Q35799711 | Early Responding Dendritic Cells Direct the Local NK Response To Control Herpes Simplex Virus 1 Infection within the Cornea |
| Q33944680 | Ectopic expression of retinoic acid early inducible-1 gene (RAE-1) permits natural killer cell-mediated rejection of a MHC class I-bearing tumor in vivo |
| Q26822893 | Effects of Peptide on NK cell-mediated MHC I recognition |
| Q36371801 | Elimination In Vivo of Developing T Cells by Natural Killer Cells |
| Q90393768 | Evidence of functional Cd94 polymorphism in a free-living house mouse population |
| Q40580566 | Expansion and Protection by a Virus-Specific NK Cell Subset Lacking Expression of the Inhibitory NKR-P1B Receptor during Murine Cytomegalovirus Infection. |
| Q61800535 | Exploiting NK Cell Surveillance Pathways for Cancer Therapy |
| Q33766787 | Expression of CD226 is associated to but not required for NK cell education |
| Q80362773 | Expression of murine killer immunoglobulin-like receptor KIRL1 on CD1d-independent NK1.1(+) T cells |
| Q36376242 | Expression of natural killer receptor alleles at different Ly49 loci occurs independently and is regulated by major histocompatibility complex class I molecules. |
| Q37137278 | Expression of the inhibitory Ly49E receptor is not critically involved in the immune response against cutaneous, pulmonary or liver tumours. |
| Q34414261 | Expression of the mouse MHC class Ib H2-T11 gene product, a paralog of H2-T23 (Qa-1) with shared peptide-binding specificity |
| Q97521731 | Flattening the COVID-19 Curve With Natural Killer Cell Based Immunotherapies |
| Q51746049 | Functional characterization of a conserved pair of NKR-P1 receptors expressed by NK cells and T lymphocytes in liver and gut. |
| Q31145570 | Genes encoding putative natural killer cell C-type lectin receptors in teleostean fishes |
| Q42279934 | High mTOR activity is a hallmark of reactive natural killer cells and amplifies early signaling through activating receptors |
| Q34017978 | Host immune response to intracellular bacteria: A role for MHC-linked class-Ib antigen-presenting molecules |
| Q36732703 | Human CD8+ intraepithelial lymphocytes: a unique model to study the regulation of effector cytotoxic T lymphocytes in tissue |
| Q90439411 | Human Natural Killer Receptors, Co-Receptors, and Their Ligands |
| Q34825943 | IFN-gamma protects short-term ovarian carcinoma cell lines from CTL lysis via a CD94/NKG2A-dependent mechanism |
| Q35001616 | IFN-gamma suspends the killing license of anti-tumor CTLs |
| Q35847866 | IFN-gamma-mediated negative feedback regulation of NKT-cell function by CD94/NKG2. |
| Q49797904 | Identification of novel polymorphisms and two distinct haplotype structures in dog leukocyte antigen class I genes: DLA-88, DLA-12 and DLA-64. |
| Q35096191 | Immune functions encoded by the natural killer gene complex |
| Q36434639 | Immune reconstitution and graft-versus-host reactions in rat models of allogeneic hematopoietic cell transplantation |
| Q39429911 | Immune selection during tumor checkpoint inhibition therapy paves way for NK-cell "missing self" recognition |
| Q30413179 | Impaired natural killer cell self-education and "missing-self" responses in Ly49-deficient mice |
| Q33894585 | Implications of CD94 deficiency and monoallelic NKG2A expression for natural killer cell development and repertoire formation |
| Q52430441 | Improved Murine MHC-Deficient HLA Transgenic NOD Mouse Models for Type 1 Diabetes Therapy Development. |
| Q36404648 | In vivo identification of glycolipid antigen-specific T cells using fluorescent CD1d tetramers |
| Q39758122 | In vivo tumor cell rejection induced by NK cell inhibitory receptor blockade: maintained tolerance to normal cells even in the presence of IL-2. |
| Q34308218 | Inhibitory NK-cell receptors on T cells: witness of the past, actors of the future |
| Q61448753 | Inhibitory Receptor Crosslinking Quantitatively Dampens Calcium Flux Induced by Activating Receptor Triggering in NK Cells |
| Q35035716 | Innate immunity to cytomegalovirus: the Cmv1 locus and its role in natural killer cell function |
| Q38712079 | Innate lymphoid cells and the MHC. |
| Q47864723 | Interaction between natural killer and dendritic cells: the role of CD40, CD80 and major histocompatibility complex class i molecules in cytotoxicity induction and interferon-gamma production. |
| Q35904393 | Interplay of natural killer cells and their receptors with the adaptive immune response |
| Q38015720 | Intraepithelial lymphocytes in celiac disease immunopathology |
| Q36179663 | Intratumoral hu14.18-IL-2 (IC) induces local and systemic antitumor effects that involve both activated T and NK cells as well as enhanced IC retention. |
| Q38339912 | Isoforms of the nonclassical class I MHC antigen H2-Q5 are enriched in brain and encode Qdm peptide |
| Q36959049 | KLRE/I1 and KLRE/I2: a novel pair of heterodimeric receptors that inversely regulate NK cell cytotoxicity |
| Q46634172 | Licensing of natural killer cells by host major histocompatibility complex class I molecules |
| Q46027985 | Ligands for the murine NKG2D receptor: expression by tumor cells and activation of NK cells and macrophages. |
| Q43663291 | Long-term donor chimerism after MHC (RT1) mismatched bone marrow transplantation in the rat: the role of host alloreactive NK cells |
| Q47265762 | Low number of H-2Dd-negative haematopoietic cells in mixed bone marrow chimeras convey in vivo tolerance to H-2Dd-negative cells but fail to prevent resistance to H-2Dd-negative leukaemia |
| Q42597849 | Ly49 genes in non-rodent mammals |
| Q47877843 | Ly49E expression points toward overlapping, but distinct, natural killer (NK) cell differentiation kinetics and potential of fetal versus adult lymphoid progenitors |
| Q36868743 | MHC class I-specific inhibitory receptors and their ligands structure diverse human NK-cell repertoires toward a balance of missing self-response |
| Q44947881 | MHC-Peptide Tetramers to Visualize Antigen-Specific T Cells |
| Q52936170 | MHC-dependent shaping of the inhibitory Ly49 receptor repertoire on NK cells: evidence for a regulated sequential model |
| Q34494545 | Mammalian non-classical major histocompatibility complex I and its receptors: Important contexts of gene, evolution, and immunity |
| Q33649805 | Mechanisms of antigen presentation |
| Q33617746 | Mechanisms of self-nonself discrimination and possible clinical relevance |
| Q33836834 | Mesenteric B cells centrally inhibit CD4+ T cell colitis through interaction with regulatory T cell subsets |
| Q38808390 | Microenvironmental stresses induce HLA-E/Qa-1 surface expression and thereby reduce CD8(+) T-cell recognition of stressed cells |
| Q36691736 | Modulation of CD8+ CTL effector function by fibroblasts derived from the immunoprivileged cornea |
| Q35776463 | Mouse NK cell–mediated rejection of bone marrow allografts exhibits patterns consistent with Ly49 subset licensing |
| Q98178325 | NK Cells Negatively Regulate CD8 T Cells to Promote Immune Exhaustion and Chronic Toxoplasma gondii Infection |
| Q40803957 | NK and T cells constitute two major, functionally distinct intestinal epithelial lymphocyte subsets in the chicken |
| Q33829849 | NK cell activation: distinct stimulatory pathways counterbalancing inhibitory signals |
| Q36543814 | NK cell receptors as tools in cancer immunotherapy. |
| Q35035731 | NK cell receptors: emerging roles in host defense against infectious agents |
| Q38196030 | NK cell self tolerance, responsiveness and missing self recognition |
| Q34332682 | NK cells and NKT cells in innate defense against viral infections |
| Q38676458 | NK cells and cancer: you can teach innate cells new tricks. |
| Q37088602 | NK cells and their receptors |
| Q35591444 | NK cells: immune cross-talk and therapeutic implications |
| Q38568884 | NK cells: tuned by peptide? |
| Q33739557 | NKG2A inhibits invariant NKT cell activation in hepatic injury |
| Q42426824 | NKG2C, HLA-E and their association with psoriasis |
| Q39056737 | NKG2C/E Marks the Unique Cytotoxic CD4 T Cell Subset, ThCTL, Generated by Influenza Infection |
| Q34333607 | NKT cell stimulation with glycolipid antigen in vivo: costimulation-dependent expansion, Bim-dependent contraction, and hyporesponsiveness to further antigenic challenge |
| Q49351739 | Natural Killer Cell Education and the Response to Infection and Cancer Therapy: Stay Tuned |
| Q91939030 | Natural Killer Cell Receptor Genes in Camels: Another Mammalian Model |
| Q41926180 | Natural killer cell education in mice with single or multiple major histocompatibility complex class I molecules |
| Q36232756 | Natural killer cell immune responses |
| Q33922176 | Natural killer cell surveillance of intracellular antigen processing pathways mediated by recognition of HLA-E and Qa-1b by CD94/NKG2 receptors. |
| Q35622883 | Natural killer cells and cancer |
| Q34342650 | Natural killer cells and nitric oxide. |
| Q37124504 | Natural killer cells and their receptors in multiple sclerosis |
| Q36209713 | Non-classical MHC class I molecules on intestinal epithelial cells: mediators of mucosal crosstalk |
| Q36368400 | Nonstochastic coexpression of activation receptors on murine natural killer cells |
| Q47234982 | Overlapping Peptide Library to Map Qa-1 Epitopes in a Protein. |
| Q33829844 | Paired inhibitory and triggering NK cell receptors for HLA class I molecules. |
| Q38986444 | Paired opposing leukocyte receptors recognizing rapidly evolving ligands are subject to homogenization of their ligand binding domains |
| Q52597633 | Pathogen Recognition by CD4 Effectors Drives Key Effector and Most Memory Cell Generation Against Respiratory Virus |
| Q35794626 | Pathogen-host standoff: immunity to polyomavirus infection and neoplasia |
| Q28512975 | Phylogenetic and functional conservation of the NKR-P1F and NKR-P1G receptors in rat and mouse |
| Q37041684 | PlexinD1 glycoprotein controls migration of positively selected thymocytes into the medulla |
| Q48166077 | Polymorphism and conservation of the genes encoding Qa1 molecules |
| Q74548166 | Positive selection of a Qa-1-restricted T cell receptor with specificity for insulin |
| Q47210839 | Proliferative and cytotoxic response of human natural killer cells exposed to transporter associated with antigen-processing-deficient cells. |
| Q28265298 | Qa-1, a nonclassical class I histocompatibility molecule with roles in innate and adaptive immunity |
| Q64062638 | Qa-1-Restricted CD8 T Cells Can Compensate for the Absence of Conventional T Cells during Viral Infection |
| Q33909456 | Rapid evolution of NK cell receptor systems demonstrated by comparison of chimpanzees and humans |
| Q39442853 | Rat and Mouse CD94 Associate Directly with the Activating Transmembrane Adaptor Proteins DAP12 and DAP10 and Activate NK Cell Cytotoxicity |
| Q36375639 | Recognition of the class Ib molecule Qa-1(b) by putative activating receptors CD94/NKG2C and CD94/NKG2E on mouse natural killer cells |
| Q34473170 | Recognition of the nonclassical MHC class I molecule H2-M3 by the receptor Ly49A regulates the licensing and activation of NK cells. |
| Q34167935 | Recognition of tumor cells by the innate immune system |
| Q34496462 | Recognition of tumors by the innate immune system and natural killer cells |
| Q37039579 | Regulation of CD8+ regulatory T cells: Interruption of the NKG2A-Qa-1 interaction allows robust suppressive activity and resolution of autoimmune disease |
| Q37256962 | Regulation of NK cell responsiveness to achieve self-tolerance and maximal responses to diseased target cells |
| Q36191417 | Regulation of activated CD4+ T cells by NK cells via the Qa-1-NKG2A inhibitory pathway. |
| Q46734905 | Restricted expression of C-type lectin-like natural killer receptors by CD8 T cells in the murine small intestine |
| Q28591835 | Retinoic acid early inducible genes define a ligand family for the activating NKG2D receptor in mice |
| Q36518933 | Self-tolerance of natural killer cells |
| Q37240705 | Synergistic inhibition of natural killer cells by the nonsignaling molecule CD94. |
| Q91062454 | Synergized regulation of NK cell education by NKG2A and specific Ly49 family members |
| Q40235067 | T and B lymphocytes exert distinct effects on the homeostasis of NK cells |
| Q37995950 | Targeting natural killer cells and natural killer T cells in cancer |
| Q28221089 | Tetrameric complexes of HLA-E, HLA-F, and HLA-G |
| Q27005990 | The CD200-CD200R1 inhibitory signaling pathway: immune regulation and host-pathogen interactions |
| Q36685564 | The CD94/NKG2 family of receptors: from molecules and cells to clinical relevance. |
| Q36557780 | The Inhibitory Receptor NKG2A Sustains Virus-Specific CD8⁺ T Cells in Response to a Lethal Poxvirus Infection |
| Q41684097 | The Molecular Mechanism of Natural Killer Cells Function and Its Importance in Cancer Immunotherapy. |
| Q35084300 | The NK cell receptor repertoire: formation, adaptation and exploitation |
| Q97636479 | The NK cell-cancer cycle: advances and new challenges in NK cell-based immunotherapies |
| Q45874664 | The Role of MHC-E in T Cell Immunity Is Conserved among Humans, Rhesus Macaques, and Cynomolgus Macaques |
| Q42212740 | The Transcription Factors T-bet and Eomes Control Key Checkpoints of Natural Killer Cell Maturation |
| Q38151853 | The central role of the cytoskeleton in mechanisms and functions of the NK cell immune synapse. |
| Q90244797 | The complex existence of γδ T cells following transplantation: the good, the bad and the simply confusing |
| Q39285519 | The hemochromatosis protein HFE 20 years later: An emerging role in antigen presentation and in the immune system |
| Q35005908 | The innate immune response to tumors and its role in the induction of T-cell immunity |
| Q33953182 | The mouse as a model for the effects of MHC genes on human disease |
| Q37206656 | The natural killer gene complex genetic locus Chok encodes Ly-49D, a target recognition receptor that activates natural killing |
| Q35838656 | The role of CD94/NKG2 in innate and adaptive immunity |
| Q38883507 | The role of MHC class Ib-restricted T cells during infection |
| Q35855834 | The role of NK cells and NK cell receptors in autoimmune disease |
| Q51994323 | The role of TCR stimulation and TGF-beta in controlling the expression of CD94/NKG2A receptors on CD8 T cells |
| Q37703518 | Tolerant and diverse natural killer cell repertoires in the absence of selection |
| Q90381772 | Towards Clinical Translation of CD8+ Regulatory T Cells Restricted by Non-Classical Major Histocompatibility Complex Ib Molecules |
| Q36368804 | Tracking the response of natural killer T cells to a glycolipid antigen using CD1d tetramers |
| Q40628548 | Transcriptional Control of MurineCD94Gene: Differential Usage of Dual Promoters by Lymphoid Cell Types |
| Q33371835 | Upregulation of CD94 on CD8+T cells in anterior chamber-associated immune deviation |
| Q33594882 | Uterine Natural Killer Cells: Functional Distinctions and Influence on Pregnancy in Humans and Mice |
| Q34786959 | Variable receptors controlling activation and inhibition of NK cells |
| Q35136013 | What does it take to make a natural killer? |
| Q77070950 | Xenotransplantation |